These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15821005)

  • 21. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study).
    Terkelsen CJ; Nørgaard BL; Lassen JF; Poulsen SH; Gerdes JC; Sloth E; Gøtzsche LB; Rømer FK; Thuesen L; Nielsen TT; Andersen HR
    Eur Heart J; 2006 Feb; 27(3):267-75. PubMed ID: 16227311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [QT dispersion and myonecrosis after stent percutaneous coronary intervention].
    Marazia S; Zimarino M; Torge G; Pasquale M; Caputo M; Floris F; Leonzio L; Di Iorio C; De Caterina R
    Ital Heart J Suppl; 2004 Nov; 5(11):861-7. PubMed ID: 15633430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction.
    Aström-Olsson K; Hedström E; Hultén LM; Wiklund O; Arheden H; Ohlin AK; Gottsäter A; Ohlin H
    J Invasive Cardiol; 2007 Nov; 19(11):452-6. PubMed ID: 17986718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
    Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
    Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations.
    Miller WL; Garratt KN; Burritt MF; Lennon RJ; Reeder GS; Jaffe AS
    Eur Heart J; 2006 May; 27(9):1061-9. PubMed ID: 16481332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia.
    Hjortshøj S; Dethlefsen C; Kristensen SR; Ravkilde J
    Clin Chim Acta; 2009 May; 403(1-2):114-20. PubMed ID: 19361451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels.
    Saleh N; Braunschweig F; Jensen J; Tornvall P
    Am J Cardiol; 2006 Mar; 97(6):830-4. PubMed ID: 16516584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris.
    Gravning J; Ueland T; Mørkrid L; Endresen K; Aaberge L; Kjekshus J
    Scand Cardiovasc J; 2008 Jun; 42(3):214-21. PubMed ID: 18569954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction].
    Ma XJ; Zhang XH; Luo M; Li CM; Shao JH
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):114-7. PubMed ID: 17418019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial.
    Kaltoft A; Bøttcher M; Nielsen SS; Hansen HH; Terkelsen C; Maeng M; Kristensen J; Thuesen L; Krusell LR; Kristensen SD; Andersen HR; Lassen JF; Rasmussen K; Rehling M; Nielsen TT; Bøtker HE
    Circulation; 2006 Jul; 114(1):40-7. PubMed ID: 16801464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention.
    Ozdol C; Gulec S; Rahimov U; Atmaca Y; Turhan S; Erol C
    Thromb Res; 2007; 119(4):453-9. PubMed ID: 17157900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of serum cardiac markers following successful percutaneous coronary intervention and subsequent exercise capacity in patients with chronic stable angina: a pilot study.
    Williams SG; Stables RH; Wright DJ; Taylor S; Thompson D; Tan LB
    Cardiology; 2005; 103(2):63-7. PubMed ID: 15539783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
    Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm.
    Cho DK; Choi JO; Kim SH; Choi J; Rhee I; Ki CS; Lee SC; Gwon HC
    Coron Artery Dis; 2007 Mar; 18(2):83-7. PubMed ID: 17301598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.